Analyst Ratings for WAVE Life Sciences (WVE)
WVE Rating Summary
WVE Price Target Summary
- Highest: $43.00 (Canaccord)
- Lowest: $11.00 (UBS)
- Average: $22.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$22.50 (+618.8%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$22.50 (+618.8%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | William Blair | Alethia Young | New Coverage | Outperform (N/A) |
N/A (N/A) |
3.09 (3.13) |
1.29% | Details |
| 10/14/2026 | UBS | N/A | New Coverage | Buy (N/A) |
11.00 (N/A) |
3.14 (3.13) |
-0.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
